10 years ago

Mologic Secures £3 Million Funding for Point-of-Care Diagnostics

  • Mologic, a UK-based developer of point-of-care diagnostic devices, has raised £3 million in funding from Calculus Capital

  • The company plans to use the funds for commercialization, clinical trials, and regulatory approvals to bring its medical diagnostic technology to market

  • Mologic is developing a pipeline of diagnostic products, including systems for patients with long-term respiratory problems

  • The company aims to reach market readiness with a series of products within the next three years.

      • ProblemHealthcare

      "It's difficult for patients with long term respiratory problems to manage their condition themselves. This can lead to poorer lung function and a need for more frequent medical intervention."

      Solution

      "Mologic is developing a range of diagnostic devices that allow patients to manage their own respiratory conditions at home. These devices are designed to be easy to use and provide accurate results, allowing patients to track their progress and adjust their medication accordingly."

      Covered on